RedHill Biopharma Ltd (RDHL)

[Amatuer17]

RHB-104 - MAP - Crohn's

Very good article - http://www.gastroendonews.com/In-the-News/Article/08-17/A-MAP-for-Crohn-s-Disease-Old-Theory-Gains-Momentum/42150

You need to read till end to find mention of RHB-104

------
"MAP skeptics and proponents may soon have the answers they seek. RHB-104, an ongoing Phase III, randomized controlled trial of AMAT in approximately 300 Crohn’s patients with moderate to severe disease, may provide an interim efficacy analysis this summer. The trial is being conducted by RedHill Biopharma, using the AMAT formula developed by Dr. Borody, who is also a member of RedHill’s advisory board.

“I won’t even go into the apple carts that will be upset when our theories are incontrovertibly proven,” Dr. Chamberlin said. “We’re talking about massive industries—immunosuppressive therapies, not to mention the dairy industry—hundreds of billions of dollars-a-year industries that are built on the wrong assumptions.”